Next Pharmaceuticals Grows through Acquisition of Sytrinol® Product and Related Intellectual Property from KGK Synergize
Salinas, California – June 5, 2013 – Next Pharmaceuticals has purchased worldwide distribution rights, along with all patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize. Sytrinol is currently sold through Proprietary Nutritionals Inc., who holds distribution rights through December 31, 2013. “Sytrinol is an exciting addition to our portfolio of patented, proven and science based products”, said Regan Miles, President of Next Pharmaceuticals. “New product acquisition is one of Next’s several key growth strategies”. Sytrinol is a patented and proprietary